Tech Company Financing Transactions
Avelas Biosciences Funding Round
Avelas Biosciences closed a $20 million Series C financing round on 8/19/2016. Backers included Pharmstandard, Alexandria Venture Investments and Avalon Ventures.
Transaction Overview
Pharmstandard (Lead Investor) (Kevin Kinsella)
Alexandria Venture Investments
Avalon Ventures (Jay Lichter)
Company Information
La Jolla, CA 92037
USA
Management Team
Browse more venture capital transactions:
Prev: 8/19/2016: NextHealth Technologies venture capital transaction
Next: 8/19/2016: Happify venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs